Larvol Delta - Low-Dose-Reduced-Frequency-Nivolumab-for-the-Treatment-of-Unresectable-or-Metastatic-Cancer-AFFORD-IO-Trial

ABP 206 (nivolumab biosimilar) - Amgen

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Nivocad (nivolumab biosimilar) - Biocad

http://clinicaltrials.gov/ct2/show/NCT07576725

Sep 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next